StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) stock

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.90−0.35 (-4.83%)

Close on Nov 16, 2026Market cap $320.01MP/E –Yield –

MapLight Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

MapLight Therapeutics's enterprise value was $35.14M on Nov 11, 2026, against -$216.19M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$35.14M–
2025Dec 31, 2025-$213.01M–

More MapLight Therapeutics figures

See a number that looks wrong?